Envoy Medical (COCH) vs Myomo (MYO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Myomo (MYO) has outperformed Envoy Medical (COCH) over the past year, gaining 19.5% versus a loss of 29.3%. Over five years, MYO leads with a -89.4% price change compared with -93.2% for COCH. Myomo is the larger company by market cap ($56.6 million vs $50.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COCH | MYO |
|---|---|---|
| Share price | $0.6578 | $1.43 |
| Market cap | $50.78M | $56.64M |
| 1-day change | +0.03% | +1.42% |
| YTD return | -0.51% | +54.95% |
| 1-year return | -29.29% | +19.49% |
| 5-year return | -93.25% | -89.43% |
| EPS (TTM) | $-0.76 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.02 | $1.89 |
| 52-week low | $0.363 | $0.605 |
| Distance from 52-week high | -35.51% | -24.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +229.89% | +224.48% |
| Average volume | 155.47K | 493.94K |
| Shares outstanding | 77.19M | 39.61M |
| Employees | 43 | 194 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MYO has outperformed COCH by 48.8 percentage points over the past year.
About Envoy Medical
COCH stock →Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.
Health Care · Industrial Specialties · 43 employees
About Myomo
MYO stock →Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Health Care · Industrial Specialties · 194 employees
COCH vs MYO FAQ
Which is bigger, Envoy Medical or Myomo?
Myomo (MYO) is larger, with a market capitalization of $56.64M compared with $50.78M for Envoy Medical (COCH).
Which stock has performed better over the past year, COCH or MYO?
MYO returned +19.49% over the past 12 months, compared with -29.29% for COCH (price return, excluding dividends). Past performance does not predict future results.
Are Envoy Medical and Myomo in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.